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Propolis is a sticky dark-colored material showing a very complex chemical composition
that honeybees collect from plants. It has been used in folk medicine since ancient times, due
to several biological properties, such as antimicrobial, anti-inflammatory, antioxidant and
immunomodulatory activities, among others. Its antitumor action in vivo and in vitro has also
been reported, using propolis extracts or its isolated compounds. The goal of this work was to
evaluate propolis’s cytotoxic action in vitro on human laryngeal epidermoid carcinoma (Hep-2)
cells. These cells were incubated with different concentrations of this bee product for different
time periods, and morphology and the number of viable HEp-2 cells analyzed. Data showed
that propolis exhibited a cytotoxic effect in vitro against HEp-2 cells, in a dose- and time-
dependent way. Propolis solvent had no effects on morphology and number of viable cells,
proving that the cytotoxic effects were exclusively due to propolis components. Since humans
have been using propolis for a long time, further assays will provide a better comprehension of
propolis’s antitumor action.
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Introduction
Propolis has attracted researchers’ interest in the last
decades, because of its several biological and pharmaco-
logical properties, such as immunomodulatory, antimi-
crobial, antitumor, anti-inflammatory, antioxidant,
among others (1). Besides, propolis-containing products
have been intensely marketed by the pharmaceutical
industry and health-food stores (2).
Propolis is a resinous material collected by bees from bud
and exudates of plants, which is mixed with products
of their salivary glands and wax. Its color varies from
green, red to dark brown. Propolis has a characteristic
smell and shows adhesive properties, because it strongly
interacts with oils and proteins of the skin.
Several researchers have reported the antitumoral
property of propolis both in vivo and in vitro. Propolis’s
antiproliferative activity on tumor cells has been
demonstrated and some responsible compounds have
been isolated (2,3).
Our group verified that propolis (10% treatment for 3
days) increased the cytotoxic activity of natural killer cells
against murine lymphoma (4). This finding confirmed a
previous observation that propolis administration over
a short term to animals increases the immunological
response (5). In our projects, we also evaluated the
potential of propolis in carcinogenesis and mutagenesis
assays (6,7). Propolis cytotoxic effects in vitro were also
found on canine transmissible venereal tumor (8).
HEp-2 cell line is derived from laryngeal carcinoma
cells of human nasopharyngeal mucosa. Being slow-
growing tumors, these cells develop in animal hosts as
well as in tissue culture (9). Propolis effects on these
cells have not been investigated. Thus, the present work
was carried out in order to verify a possible cytotoxic
action of propolis on HEp-2 cells, evaluating its
morphology and the number of viable cells after
incubation with propolis in different concentrations and
time periods.
For reprints and all correspondence: Jose ´ Maurı´cio Sforcin, Biosciences
Institute, UNESP, 18618-000 Botucatu, S.P., Brazil. Tel: +55 14
38116058; Fax: +55 14 38153744; E-mail: sforcin@ibb.unesp.br
 2007 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original worki s
properly cited.Methods
Propolis Sample
Propolis was collected in the Beekeeping Section, UNESP,
Campus of Botucatu, Brazil. Propolis was ground and
30% ethanolic extracts of propolis were prepared (30g of
propolis, making the volume 100ml with 70% ethanol),
in the absence of bright light, at room temperature, with
moderate shaking. After a week, extracts were filtered
and the dry weight of the extracts was calculated
(120mg/ml) (10). Propolis’s chemical composition was
investigated using thin-layer chromatography (TLC),
gas-chromatography (GC) and gas chromatography-mass
spectrometry (GC-MS) analysis (11–13).
Propolis was diluted in minimum essential media (MEM)
supplemented with 0.1g/l of L-glutamine, 2.2g/l sodium
bicarbonate, 10ml/l non-essential amino acids and 10%
fetal calf serum (Sigma), and specific dilutions of
this solution were prepared for each assay in order to
achieve different propolis concentrations: 5, 10, 25, 50 and
100mg/well. The same procedure was carried out with 70%
ethanol (propolis solvent), in order to obtain 0.03, 0.06,
0.15, 0.29 and 0.59% ethanol, which are the respective
concentrations of alcohol in propolis concentrations.
HEp-2 Cells Culture
HEp-2 cells were grown in MEM as described earlier and
cultivated at 37 C and 5% CO2. First, cells in 25cm
2 flasks
were washed with 5–10ml of MEM, and afterwards 1–2ml
of trypsin (0, 2% trypsin in 5% EDTA) were added to each
flask until cell detachment. Cells were counted using a
hemocytometer and cultivated in a 96 well, U-bottom plate
(Corning) at a final concentration of 2 10
5 cells/well (8).
Propolis Cytotoxicity Assay
HEp-2 cell cultures, after 80% confluent monolayers,
were incubated with propolis or its solvent (ethanol) in
MEM, using a 96 well plate, incubating at 37 C and 5%
CO2, for 6, 24, 48 and 72h. Control wells contained only
the same cell number in the same media. Each propolis or
ethanol concentration was assayed in triplicate. After
each period, cell morphology was evaluated microscop-
ically, as well as counting the number of viable cells in
treated and untreated cultures, by trypan blue dye
exclusion after trypsinization (8). Viable HEp-2 cells are
epithelioid-shaped cells with few rounded ones.
Statistical Analysis
Friedman non-parametric test was employed in order to
compare propolis effects along time. Kruskal–Wallis test
was used to evaluate propolis concentrations effect in
each time period (14).
Results
Propolis Exhibited a Cytotoxic Effect In Vitro
in a Dose- and Time-dependent Manner
HEp-2 cells showed a typical morphology after 6, 24,
48 and 72h of incubation with propolis, using 5 and
10mg/well. In these concentrations, epithelioid-shaped
cells were observed, with few rounded cells, similar to
control. However, after 6h of incubation with 25, 50 and
100mg/well, changes in cell morphology were observed,
such as cell lysis and disorganization of the monolayer,
mainly using 100mg/wells (Fig. 1).
After 24h of incubation, propolis cytotoxic activity
was significantly detected using 100mg/well (P<0.05)
(Fig. 2), affecting monolayers and numbers of viable cells
(Fig. 4).
After 48h, cell monolayers were affected significantly
by propolis using 25 and 50mg/well (P<0.05), in
comparison to control cells, showing a non-typical
monolayer pattern (Fig. 3).
Propolis Affected the Number of Viable HEp-2 Cells
In Vitro
The number of viable cells diminished after incubation
with propolis in different concentrations and time
periods, in a dose- and time-dependent manner (Fig. 4).
Propolis Solvent (70% ethanol) Showed No Effects on
Hep-2 Cells In Vitro
Seventy percent ethanol, in all dilutions (0.03, 0.06, 0.15,
0.29 and 0.59%–the respective concentrations of alcohol
in propolis concentrations), had no effect either on cell
morphology or on cell viability.
Discussion
Propolis’s antitumor action has been widely investigated
by several authors, and our group has also evaluated its
effects both in vivo and in vitro (4,6–7).
Our propolis samples, collected in the Beekeeping
Section of the University, UNESP, Campus of Botucatu,
were analyzed by GC, GC-MS and TLC, revealing that its
main components are phenolic compounds (flavonoids,
aromatic acids, benzopyranes), di- and triterpenes, essen-
tial oils, among others.
The main constituents of our propolis sample
were isolated and identified: flavonoids are present in
small quantities in Brazilian propolis (kaempferid,
5,6,7-trihydroxy-3,40-dimethoxyflavone, aromadendrine-
40-methyl ether); a prenylated p-coumaric acid and two
benzopyranes: E and Z 2,2-dimethyl-6-carboxyethenyl-
8-prenyl-2H-benzopyranes); essential oils (spathulenol,
(2Z,6E)-farnesol, benzyl benzoate and prenylated
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p-coumaric acid, ferulic acid, caffeic acid, which are
common for poplar propolis, 3,5-diprenyl-p-coumaric
acid, 2,2-dimethyl-6-carboxy-ethenyl-8-prenyl-2H-1-
benzo-pyran); di- and triterpenes, among others (11–13).
The main vegetal sources of our propolis samples are
Baccharis dracunculifolia DC, Eucalyptus citriodora Hook
and Araucaria angustifolia (Bert.) O. Kuntze (15).
In this work, one may verify that propolis showed a
cytotoxic effect in vitro against HEp-2 cells, in a dose-
and time-dependent manner. Higher concentrations of
propolis showed a short-term action, whereas its lower
concentrations were effective with time. Propolis solvent
had no effects on morphology and number of viable cells,
suggesting that cytotoxic effects were exclusively due to
propolis components. In our assays, the propolis samples
collected in our university was employed. Samples from
different geographic origins may show different chemical
compositions, however, similarity in their activities may
be found, due to different responsible compounds (16).
The antiproliferative action of propolis on tumor cells
may be the result of the synergistic effect of propolis
constituents, and some isolated compounds have been
investigated (17). Caffeic acid phenethyl ester (CAPE) is
one of propolis constituents most investigated with
regards to antitumor action.
CAPE had a dose-dependent effect on cytotoxicity of C6
glioma cells, reducing viability to 42% in relation to
control, and increasing the proportion of hypodiploid
DNA, as indication of apoptosis (18). According to
reports, antitumor activity of propolis also occurs through
the induction of apoptosis via caspase pathways (19).
CAPE also interferes in cell cycle arrest. After
incubation with CAPE for 24h, cell number percentage
of C6 glioma cells in G0/G1 phase increased to 85%, due
to inhibition of retinoblastoma protein (pRB) phosphor-
ylation. Phosphorylation of pRB by cyclin-dependent
Figure 1. HEp-2 cell morphology: monolayers after 6h of incubation
with 5, 10, 25, 50 and 100mg/well of propolis (P) in comparison to
control (C) (20 ). This figure represents five similar assays.
Figure 2. HEp-2 cell morphology: monolayers after 24h of incubation
with 100mg/well of propolis (P) in comparison to control (C) (20 ).
This figure represents five similar assays.
Figure 3. HEp-2 cell morphology: monolayers after 48h of incubation
with 25, 50 and 100mg/well of propolis (P) in comparison to control (C)
(20 ). This figure represents five similar assays.
0
50.000
100.000
150.000
200.000
250.000
300.000
0h 6h 24h 48h 72h
time
m
e
d
i
a
n
Control 
P5
P10
P25
P50
P100
Figure 4. Median of HEp-2 cells number after incubation with different
propolis concentrations (5, 10, 25, 50 and 100mg/well) for 6, 24, 48 and
72h. This figure represents five similar assays.
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regulation of S-phase entry, and appears to define the
restriction point in the late G1 phase (20). CAPE
derivatives were investigated on oral cancer using
cultured cancer cell line (squamous cell
carcinoma=SAS; oral epidermoid carcinoma-Meng
1=OEC-M1) and normal human oral fibroblast
(NHOF), examining their effects on cell growth pattern,
their cytotoxicity and changes in the cell cycle. CAPEs
showed cytotoxic effects on tumor cells but not on
NHOF cell line. Flow cytometric analysis showed OEC-
M1 cell arrest at G2/M phase. Such differential effects on
cancer and normal cells suggested that these compounds
might be useful in oral cancer chemotherapy (21).
CAPE prolonged the survival of mice implanted with
colon adenocarcinoma cells (CT26 cells), reducing the
pulmonary metastatic capacity of these cells (22). Recently,
according to one suggestion the in vivo antitumor activity
of propolis and some of its constituents is associated with
their immunomodulatory action in mice, mainly due to
augmentation of non-specific antitumor immunity, via
macrophage activation, which in turn could produce
soluble factors and interfere directly in tumor cells or in
functions of other immune cells (23).
Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid),
another propolis constituent with antitumor action and
present in Brazilian propolis, was investigated for its
effects on colon carcinogenesis, inducing G(0)/G(1) arrest
via stimulation of Cip1/p21 expression in human colon
cancer cells (24). Artepillin C induces apoptosis in human
leukemia cell lines of different phenotypes (25).
Although the constituents of propolis responsible for its
cytotoxic action were not investigated in this research,
our work opens a new perspective for further investiga-
tion. The large amount of work dealing with antitumor
action of propolis and its constituents indicates their
promising usefulness, and claims for new investigations,
in order to explore propolis’s potential as a cancer
chemopreventive and chemotherapeutic agent.
Since propolis shows several biological properties
(26–29) and it is used as an alternative medicine for
health amelioration and disease prevention, our
laboratory is investigating propolis action in immunos-
suppressed mice, bearing melanoma cells.
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